Skip to content
DNDi Logo
  • DNDi JAPAN
  • DNDi LATIN AMERICA
  • DNDi NORTH AMERICA
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Menu
  • ABOUT US
        • ABOUT US
        • BUSINESS MODEL
        • DNDi‘s POLICIES
        • DNDi WORLDWIDE
        • OUR PEOPLE
        • 2016 ANNUAL REPORT
        • PREVIOUS ANNUAL REPORTS
        • E-NEWS
        • JOB OPPORTUNITIES
        • CONTACT US
    • Close
  • DISEASES & PROJECTS
        • DISEASES
          • SLEEPING SICKNESS
          • LEISHMANIASIS
          • CHAGAS DISEASE
          • PAEDIATRIC HIV
          • FILARIAL DISEASE
          • MYCETOMA
          • HEPATITIS C
          • MALARIA
        • PROJECT PORTFOLIO
        • DNDi's Portfolio
        • GLOBAL ANTIBIOTIC R&D PARTNERSHIP (GARDP)
        • TARGET PRODUCT PROFILES
        • CLINICAL TRIALS
        • OPEN INNOVATION PORTAL
    • Close
  • ACHIEVEMENTS
        • DNDi ACHIEVEMENTS
          • ASAQ (Malaria)
          • ASMQ (Malaria)
          • NECT (Sleeping Sickness)
          • PAEDIATRIC BENZNIDAZOLE (Chagas)
          • SSG&PM (Kala azar)
          • NEW VL TREATMENTS – ASIA (Kala azar)
          • SUPERBOOSTER THERAPY (Paediatric HIV/TB)
    • Close
  • STRENGTHENING CAPACITY
        • OVERVIEW
          • LEAP PLATFORM
          • HAT PLATFORM
          • CHAGAS PLATFORM
          • REDELEISH NETWORK
        • TECHNOLOGY TRANSFER ASAQ
        • TECHNOLOGY TRANSFER ASMQ
    • Close
  • ADVOCACY
      • ADVOCACY UPDATES
      • ACCESS
      • INTELLECTUAL PROPERTY
    • Close
  • MEDIA CENTRE
        • OVERVIEW
        • NEWS, VIEWS & STORIES
        • PRESS KIT
        • PRESS RELEASES
        • IN THE MEDIA
        • OUR PUBLICATIONS
        • ANNUAL REPORT
        • E-NEWS
        • MULTIMEDIA
        • SCIENTIFIC ARTICLES
        • EVENTS
    • Close
  • PARTNERS
      • OVERVIEW
      • BUSINESS MODEL
      • PARTNERS
      • BECOME A DNDi PARTNER
      • RFP
    • Close
  • DONORS
      • SUPPORT DNDi
      • HOW TO HELP
      • KEY FINANCIAL FIGURES
      • DONORS
      • DONATE
    • Close
    • Close
  • Home
  • Media Centre
  • In the Media

In the Media

El País [3 May, 2017]

“18 males, mil millones de enfermos” – “18 illnesses, 1 billion sick”

Click here to read the article

In the MediaChagas disease, Filarial diseases, HAT – Sleeping Sickness, Leishmaniasis, Mycetoma, Treatment

Post navigation

Previous
El País: “El mal oculto de siete millones de latinos”
Next
El País: “Las picaduras que te dejan ciego”

Media Centre

  • Overview
  • News, Views & Stories
    • News
    • Viewpoints
    • Stories
  • Press Kit
  • Press Releases
    • Press Releases – Other Languages
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
  • In the Media
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • Radio
    • Television
  • Our Publications
  • E-news
    • Subscribe to E-news
    • E-news Archive
    • Special Editions Archive
  • Multimedia
    • Multimedia – Podcasts
  • Scientific Articles
    • Human African Trypanosomiasis (Sleeping Sickness)
    • Visceral Leishmaniasis
    • Cutaneous Leishmaniasis
    • Filarial diseases
    • Chagas Disease
    • Malaria
    • Paediatric HIV
    • Neglected Diseases
    • GARDP
  • Events
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003

Media Centre Search

Category
Disease
Topic
Year

Recent Articles

  • Health & Medicine: “Scientists cured a deadly neurological disease using a revolutionary method”
  • Nature: “Sleeping sickness can now be cured with pills”
  • Health Analytics India: “How India can help eliminate neglected diseases”

About DNDi

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected patients.

Learn More

  • Vision & Mission
  • Business Plan
  • DNDi‘s Model
  • Diseases & Projects
  • Portfolio
  • Treatments
  • Clinical Trials
  • Annual Report
  • Scientific Articles
  • Contact Us

Work with Us

  • Donate
  • Partnership
  • RFP
  • Jobs

DNDi Worldwide

  • DNDi regional offices
  • DNDi Japan のサイトへはこちらから.
  • DNDi Latin America website
  • DNDi North America website
  • GARDP

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
  • Events

Newsletter

Sign up for the E-news newsletter

I want to receive

  • TERMS OF USE
  • PRIVACY POLICY
  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License